Research reveals differences in prescribing patterns, treatment goals, and enthusiasm for emerging t...
A recent Delaware Chancery Court opinion offers a significant example of how courts may apply comple...
Under a new licensing deal announced July 8, JCR Pharmaceuticals Co. Ltd. granted Alexion Pharmaceut...
The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by th...
AstraZeneca’s rare disease business Alexion returns to JCR Pharmaceuticals for another deal, this ti...